Towards defining antigenic targets for antibodies in multiple sclerosis

Towards defining antigenic targets for antibodies in multiple sclerosis

Библиографические подробности
Главные авторы:	Littleton, E, Dreger, M, Palace, J, Vincent, A
Формат:	Conference item
Опубликовано:	2006

Схожие документы

Immunocapture and identification of cell membrane protein antigenic targets of serum autoantibodies.
по: Littleton, E, и др.
Опубликовано: (2009)

An approach to the identification of targets of autoantibodies in multiple sclerosis
по: Littleton, E, и др.
Опубликовано: (2004)

Serum autoantibodies against intracellular antigens in multiple sclerosis
по: Lily, O, и др.
Опубликовано: (2002)

Modafinil for multiple sclerosis fatigue: does it work?
по: Littleton, E, и др.
Опубликовано: (2010)

An audit of the use of Modafinil in clinical practice for the treatment of fatigue in multiple sclerosis patients
по: Littleton, E, и др.
Опубликовано: (2005)

Serum autoantibodies to oligodendrocyte and neuronal cell surface antigens in multiple sclerosis patients
по: Lily, O, и др.
Опубликовано: (2002)

Defining multiple sclerosis disease activity using MRI T2-weighted difference imaging.
по: Lee, M, и др.
Опубликовано: (1998)

The association of multiple sclerosis with bullous pemphigoid: is there a shared antigen response?
по: Taghipour, K, и др.
Опубликовано: (2012)

Targeting Antigen-Presenting Cells in Multiple Sclerosis Treatment
по: Piotr Szpakowski, и др.
Опубликовано: (2021-09-01)

Cytokine-defined B cell responses as Therapeutic Targets in Multiple Sclerosis
по: Rui eLi, и др.
Опубликовано: (2016-01-01)

Making the diagnosis of multiple sclerosis.
по: Palace, J
Опубликовано: (2001)

Guidelines on use of anti-IFN-beta antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-beta antibodies in multiple sclerosis.
по: Sørensen, P, и др.
Опубликовано: (2005)

The UK Multiple Sclerosis database.
по: Palace, J, и др.
Опубликовано: (1999)

Targeting Dendritic Cells with Antigen-Delivering Antibodies for Amelioration of Autoimmunity in Animal Models of Multiple Sclerosis and Other Autoimmune Diseases
по: Courtney A. Iberg, и др.
Опубликовано: (2020-06-01)

New and old treatments for multiple sclerosis.
по: Palace, J
Опубликовано: (1998)

Targeted Therapy of Multiple Sclerosis: A Case for Antigen-Specific Tregs
по: Yiya Zhong, и др.
Опубликовано: (2024-05-01)

Use of Anti-Interferon Beta Antibody Measurements in Multiple Sclerosis
по: Sørensen, P, и др.
Опубликовано: (2010)

Early treatment to prevent conversion of clinically isolated syndrome to clinically defined multiple sclerosis: a Cochrane metanalysis
по: Clerico, M, и др.
Опубликовано: (2008)

Guidelines for differential diagnosis of suspected multiple sclerosis.
по: Palace, J
Опубликовано: (2009)

Modifying disability in progressive multiple sclerosis.
по: Palace, J, и др.
Опубликовано: (2014)

Modifying disability in progressive multiple sclerosis
по: Palace, J, и др.
Опубликовано: (2014)

New treatments and azathioprine in multiple sclerosis.
по: Palace, J, и др.
Опубликовано: (1997)

A novel sensitive assay for aqueporin-4 antibodies (NMO-IgG)
по: Waters, P, и др.
Опубликовано: (2007)

Prevention of conversion of clinically isolated syndromes to clinically defined multiple sclerosis. Evidence from a Cochrane meta-analysis
по: Clerico, M, и др.
Опубликовано: (2008)

The prevalence of IgG antibodies against milk and milk antigens in patients with multiple sclerosis
по: Rittika Chunder, и др.
Опубликовано: (2023-07-01)

Multiple sclerosis associated with Leber's Hereditary Optic Neuropathy.
по: Palace, J
Опубликовано: (2009)

Outer membrane protein size and LPS O-antigen define protective antibody targeting to the Salmonella surface
по: C. Coral Domínguez-Medina, и др.
Опубликовано: (2020-02-01)

Single tumor imaging with multiple antibodies targeting different antigens
по: Yujing Sun, и др.
Опубликовано: (2012-04-01)

Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study.
по: Lily, O, и др.
Опубликовано: (2004)

Outer membrane protein size and LPS O-antigen define protective antibody targeting to the Salmonella surface
по: Domínguez-Medina, CC, и др.
Опубликовано: (2020)

Attempts to define Plasmodium Falciparum antigens with human monoclonal antibodies
по: C. Desgrandes, и др.
Опубликовано: (1986-01-01)

Defining a role for laquinimod in multiple sclerosis
по: Bernd C. Kieseier
Опубликовано: (2014-07-01)

Thalamic neurodegeneration in multiple sclerosis.
по: Cifelli, A, и др.
Опубликовано: (2002)

Running a mitoxantrone service for multiple sclerosis
по: Craner, M, и др.
Опубликовано: (2006)

Recombinant interferon-beta efficacy in preventing conversion of clinically isolated syndromes to clinically defined multiple sclerosis: a Cochrane meta-analysis
по: Clerico, M, и др.
Опубликовано: (2006)

MONOCLONAL ANTIBODY FOR MULTIPLE SCLEROSIS TREATMENT
по: E. V. Popova
Опубликовано: (2017-05-01)

Multiple sclerosis lesions: insights from imaging techniques.
по: Tomassini, V, и др.
Опубликовано: (2009)

Interleukin-17 expression in multiple sclerosis
по: Tzartos, J, и др.
Опубликовано: (2006)

Monoclonal antibodies in development in multiple sclerosis
по: J. Sastre-Garriga, и др.
Опубликовано: (2011-11-01)

The Role of Antibodies in the Pathogenesis of Multiple Sclerosis
по: Xiaoli Yu, и др.
Опубликовано: (2020-10-01)